World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
40
Citations
5878
World Ranking
8129
National Ranking
3484

Steve McGaraughty publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Steve McGaraughty sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 110 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Steve McGaraughty D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Steve McGaraughty sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 40 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Steve McGaraughty is affiliated with AbbVie in the United States and has contributed extensively to the field of medicine, with a strong focus on immunology, dermatology, neurology, physiology, and rheumatology.

Their research spans multiple topics within medical science, notably:

  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Pain Mechanisms and Treatments
  • Urticaria and Related Conditions
  • Botulinum Toxin and Related Neurological Disorders
  • Neurological disorders and treatments
  • Migraine and Headache Studies

Steve McGaraughty has published in several venues, including:

  • Cephalalgia
  • The Journal of Dermatology
  • Journal of Pharmacology and Experimental Therapeutics
  • Bioorganic & Medicinal Chemistry
  • The FASEB Journal

Frequent collaborators include:

  • Zhi Su
  • Prisca Honoré
  • Stephanie Paulsboe
  • J. Wetter
  • Marian T. Namovic

Representative publications by Steve McGaraughty are:

  • Pharmacologic characterization of atogepant: A potent and selective calcitonin gene-related peptide receptor antagonist, 2024, Cephalalgia
  • Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis, 2023, The Journal of Dermatology
  • Discovery of (R)-(3-fluoropyrrolidin-1-yl)(6-((5-(trifluoromethyl)pyridin-2-yl)oxy)quinolin-2-yl)methanone (ABBV-318) and analogs as small molecule Nav1.7/ Nav1.8 blockers for the treatment of pain, 2022, Bioorganic & Medicinal Chemistry
  • Small molecule interleukin (IL) 17A/A antagonists and antibodies blocking both IL17A/A and IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammation, 2025, Journal of Pharmacology and Experimental Therapeutics
  • Characterization of MC903 induced Atopic Dermatitis-like skin inflammation in mice, 2020, The FASEB Journal

Best Publications

  • A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

    Michael F. Jarvis;Prisca Honore;Char Chang Shieh;Mark Chapman

  • A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

    Michael F. Jarvis;Edward C. Burgard;Steve McGaraughty;Prisca Honore

  • Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.

    Jun Chen;Shailen K. Joshi;Stanley DiDomenico;Richard J. Perner

  • P2X7-related modulation of pathological nociception in rats

    S. McGaraughty;K.L. Chu;M.T. Namovic;D.L. Donnelly-Roberts

  • Effects of A‐317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

    Steve McGaraughty;Carol T Wismer;Chang Z Zhu;Joseph Mikusa

  • Painful purinergic receptors.

    Diana Donnelly-Roberts;Steve McGaraughty;Char-Chang Shieh;Prisca Honore

  • TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats

    Steve McGaraughty;Katharine L Chu;Richard J Perner;Stan DiDomenico

  • Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM

    Steve McGaraughty;Katharine L. Chu;Robert S. Bitner;Brenda Martino

  • Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.

    M. M. Heinricher;S. McGaraughty;V. Tortorici

  • Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial.

    Michael C. Rowbotham;Wolfram Nothaft;W. Rachel Duan;Yi Wang

  • Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.

    M. M. Heinricher;S. McGaraughty;D. K. Grandy

  • Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity.

    Steve McGaraughty;Mary M. Heinricher

  • Anticonvulsant and Antinociceptive Actions of Novel Adenosine Kinase Inhibitors

    Steve McGaraughty;Marlon Cowart;Michael F. Jarvis;Robert F. Berman

  • Design of adenosine kinase inhibitors from the NMR-based screening of fragments.

    Philip J. Hajduk;Arthur Gomtsyan;Stanley Didomenico;Marlon Cowart

  • A Selective Nav1.8 Sodium Channel Blocker, A-803467 [5-(4-Chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], Attenuates Spinal Neuronal Activity in Neuropathic Rats

    Steve McGaraughty;Katharine L. Chu;Marc J. C. Scanio;Michael E. Kort

  • A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats

    Michael F. Jarvis;Victoria E. Scott;Steve McGaraughty;Katharine L. Chu

  • The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine.

    M.M Heinricher;S McGaraughty;D.A Farr

  • Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry

    M M. Heinricher;S McGaraughty

  • Contributions of central and peripheral TRPV1 receptors to mechanically evoked and spontaneous firing of spinal neurons in inflamed rats.

    Steve McGaraughty;Katharine L. Chu;Brian S. Brown;Chang Z. Zhu

  • Increased WDR spontaneous activity and receptive field size in rats following a neuropathic or inflammatory injury: implications for mechanical sensitivity.

    Katharine L. Chu;Connie R. Faltynek;Michael F. Jarvis;Steve McGaraughty

Frequent Co-Authors

Prisca Honore
Prisca Honore University of Minnesota
Mary M. Heinricher
Mary M. Heinricher Oregon Health & Science University
Kennan C. Marsh
Kennan C. Marsh AbbVie (United States)
Gerard B. Fox
Gerard B. Fox Georgetown University Medical Center
James L. Henry
James L. Henry McMaster University
Robert F. Berman
Robert F. Berman University of California, Davis
Michael Williams
Michael Williams Uppsala University
Stephen W. Fesik
Stephen W. Fesik Vanderbilt University
Kevin R. Lynch
Kevin R. Lynch University of Virginia
Michael L. Gross
Michael L. Gross Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Neuroscience can open doors to a variety of careers in healthcare, research, and therapy. If you’re interested in related fields, there are flexible online options worth considering. These programs can help you build a strong foundation in human behavior and mental health, which often overlap with neuroscience principles.

Many students begin with a bachelor of psychology online to gain essential skills in psychological science. For those wishing to develop further expertise, an online masters in psychology is a popular option, providing advanced study and opening up clinical, research, or counseling roles.

Those interested in mental health therapy may explore online mft programs (Marriage and Family Therapy), ideal for students committed to helping families and couples. Additionally, for career changers or those wanting to enter social work quickly, there are 1 year msw programs online no bsw required, providing a fast track into social service roles.

Online programs make it possible to transition into new career paths or advance your education with flexibility—an asset for anyone balancing work, life, and academic ambitions.

Best Scientists Citing Steve McGaraughty

Trending Scientists

Recently Published Articles